SCHEMBL8402437

SCHEMBL8402437

COC(=O)Cc1cccc(OCC(C)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.45
PLA2G4B P0C869 1/20 0.45
GAA P10253 3/20 0.45
PPARG P37231 2/20 0.45
PPARA Q07869 2/20 0.45
ALDH1A1 P00352 3/20 0.44
GFER P55789 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSP90AB1 P08238 1/20 0.44
HTT P42858 1/20 0.43
CTBP2 P56545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766453 0.88 SLC7A5 (0.50) SLC7A5SMN1; SMN2LMNAPOLBPLA2G4B
SCHEMBL10865828 0.88 ALDH1A1 (0.50) SLC7A5LMNAPLA2G4BGAAPPARG
SCHEMBL2767480 0.84 SMN1; SMN2 (0.53) SLC7A5SMN1; SMN2GAAPPARGPPARA
SCHEMBL13178572 0.83 SLC7A5 (0.50) SLC7A5SMN1; SMN2POLBGAAALDH1A1
SCHEMBL14987498 0.83 SLC7A5 (0.45) SLC7A5SMN1; SMN2LMNAPOLBPLA2G4B
SCHEMBL31249652 0.82 SMN1; SMN2 (0.61) SLC7A5SMN1; SMN2POLBALDH1A1CYP1A2
SCHEMBL378705 0.82 SMN1; SMN2 (0.61) SLC7A5SMN1; SMN2POLBALDH1A1CYP1A2
SCHEMBL8355226 0.82 PLA2G4B (0.57) LMNAPLA2G4BGAAPPARGPPARA
SCHEMBL3334714 0.82 ALDH1A1 (0.51) SLC7A5SMN1; SMN2PLA2G4BGAAALDH1A1
SCHEMBL28588436 0.82 KMT2A (0.55) SLC7A5SMN1; SMN2LMNAPLA2G4BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5977374-A 5-(4-hydroxy-OR 4-acetoxy-benzyl)-3- triphenylmethylthiazolidine-2,4-dione and method for producing same SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5635534-A 1-PHENYL-2-(2-PHENYLOXY OR THIO)-1-METHYLETHYL)AMINOETHANOL DERIVATIVES; ALDOSE REDUCTASE INHIBITORS; NONTOXIC; ANTIDIABETIC,-OBESITY,-LIPEMIC AND HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-06-03 US disclosed
CN-1034497-C Process for the preparation of aromatic aminoalcohol derivatives useful for the treatment of diabetes and obesity SANKYO CO (JP) 1997-04-09 CN disclosed
US-5576340-A Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 1996-11-19 US disclosed
EP-0543662-B1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO CO (JP) 1996-09-18 EP disclosed
CN-1073428-A Aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic use SANKYO CO (JP) 1993-06-23 CN disclosed
EP-0543662-A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-05-26 EP disclosed